Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert’s Diabetes Technology & Therapeutics, to implement the advances made in the AID technology space. They say pivotal trials and real-world data support […]
Beta Bionics
Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’
Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. The Irvine, California-based automated insulin […]
Beta Bionics founder talks bringing ‘bionic pancreas’ to market
Around 25 years ago, Ed Damiano’s 11-month-old son developed type 1 diabetes. Damiano, a professor of mechanical engineering, made it his goal to make it easier to manage his young son’s condition. Speaking on a panel at the MassMedic 2025 MedTech Symposium in Boston earlier this month, Damiano said: “I started to think about ways […]
Beta Bionics goes public with upsized $234.6M IPO
Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering (IPO). Earlier this month, the company filed a registration statement with the SEC relating to a proposed IPO. Beta Bionics, maker of the iLet bionic pancreas, later filed a prospectus outlining its aim to bring in $114.4 million in […]
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO). Earlier this month, the maker of the iLet bionic pancreas filed a registration statement with the SEC relating to a proposed IPO. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market […]
Beta Bionics is proposing an IPO
Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public offering (IPO). The amount of shares of common stock included in the IPO and the price range remain undetermined. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market under the “BBNX” […]
Beta Bionics raises $60M Series E to support iLet bionic pancreas
Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million. This funding round adds to the $100 million Series D financing Beta Bionics completed in August 2023. Irvine, California-based Beta Bionics develops the iLet bionic pancreas, an automated insulin delivery system. The system, which streamlines diabetes […]
Beta Bionics launches iLet bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. The companies announced their plan to combine the FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with iLet last month. According to Beta Bionics, this makes iLet the first available automated insulin delivery […]
Beta Bionics to pair bionic pancreas with Abbott FreeStyle Libre 3 Plus
Beta Bionics announced that it partnered with Abbott (NYSE:ABT) to integrate the company’s CGM with its automated insulin delivery system. The companies plan to combine Abbott’s FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Beta Bionics iLet bionic pancreas. According to Beta Bionics, this will make iLet the first available AID system to […]
Beta Bionics announces 10,000th iLet bionic pancreas user
Beta Bionics announced that it reached the milestone of the 10,000th patient start on its iLet bionic pancreas for automated insulin delivery. Concord, Massachusetts–based Beta Bionics designed its iLet autonomous insulin delivery system to streamline diabetes management. The system, which reduces the burden on patients and physicians, received FDA clearance in May 2023. The system uses […]
